A Retrospective Case Series Review of the Peroxisome Proliferator-Activated Receptor Ligand Rosiglitazone in the Treatment of Atopic Dermatitis

Archives of Dermatology
doi 10.1001/archdermatol.2007.22
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Nitrolinoleic Acid: An Endogenous Peroxisome Proliferator-Activated Receptor Ligand

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Peroxisome Proliferator-Activated Receptor

English

Peroxisome Proliferator Activated Receptor

English

Peroxisome Proliferator-Activated Receptor- As a Potential Therapeutic Target in the Treatment of Preeclampsia

Hypertension
Internal Medicine
2011English

Peroxisome Proliferator-Activated Receptor Γ Agonist Rosiglitazone Increases Expression of Very Low Density Lipoprotein Receptor Gene in Adipocytes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

Peroxisome Proliferator-Activated Receptors: Targets for the Treatment of Metabolic Illnesses (Review)

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2008English

Rosiglitazone Enhances Fluorouracil-Induced Apoptosis of HT-29 Cells by Activating Peroxisome Proliferator-Activated Receptor Γ

World Journal of Gastroenterology
MedicineGastroenterology
2007English

Peroxisome Proliferator-Activated Receptor Γ-Mediated Differentiation

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2003English

Peroxisome Proliferator-Activated Receptor-Γ (PPARG; PPARγ)

Science-Business eXchange
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy